|
|
|
|
Capital Portfolio - Physical Sciences
| Company/Website |
Description |
Bionanomatrix, LLC
www.bionanomatrix.com |
BioNanomatrix (BNM) is a bionanotech designer and maker of nanostructured chips, devices and systems for fast, comprehensive, and low-cost analysis of genomic, epigenomic and proteomic information with sensitivity at the single cell / single molecule level. Currently, BNM develops nanodevices and systems for cancer diagnostics, complex disease therapeutics and personalized medicine on its NANOANALYZER™ platform. |
Nanoblox, Inc.
www.nanobloxinc.com |
Develops proprietary products and processes based on a new phase of carbon. The building block for the company's technology is a 5 nanometer diameter, sp3 carbon, nanodiamond particle with a chemically tunable surface. |
NanoMaterials Co.
www.nanomaterialscompany.com |
Developing a reactor that will be able to mass produce complex nanopowders for a host of products. |
Nano Pack, Inc.
|
NanoPack Inc. manufactures polymeric coatings and coated polymeric films, which create barriers to oxygen, carbon dioxide, water and other molecules. The coatings are water-based resin systems containing nano-scale platelets of vermiculite. |
Nanoselect Materials, Inc.
www.nanoselect-sensors.com |
Develops and manufactures dispersed stabilized nanoparticles for a variety of emerging applications. |
NanoVec, Inc.
www.nanovec.com |
NanoVec, Inc. is an early stage biotechnology company developing novel nanobiomolecular platforms for vaccines and therapeutics against infectious diseases, biothreats and cancer |
Pchem Associates
www.nanopchem.com |
PChem has developed and patented nanomaterial technology for printed electronics. The technology delivers dramatically superior conductivity at a lower cost and can be used at lower manufacturing temperatures. The unique silver nanopowder has clear and distinct advantages when compared to existing and developing materials used in printed electronics. |
Reacta Corporation
www.reactacorp.com |
Reacta provides products and solutions for enhancing the performance and stability of enzymes and other biomolecules. This is accomplished through the use and commercialization of Drexel University's patented platform technology in the area of nanoencapsulation using a sol gel mesoporous material. |
|
 |
©2008 Ben Franklin Technology Partners
of Southeastern Pennsylvania
Building 100 Innovation Center | The Navy Yard
4801 S. Broad Street, Suite 200 | Philadelphia, PA 19112
Tel. 215.972.6700 | Fax 215.972.5588 | info@sep.benfranklin.org
Directions to the Navy Yard
|
 |
| |
|
|